We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diagnosis of Variceal Bleeding and Its Control in Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00188097
Recruitment Status : Terminated
First Posted : September 16, 2005
Last Update Posted : January 19, 2006
Sponsor:
Information provided by:
University Hospital, Angers

Brief Summary:
The aim of the study was to determine the independent predictors of variceal bleeding and control of bleeding in cirrhosis as no scientific assessment have been perfomed until now

Condition or disease Intervention/treatment
Cirrhosis Behavioral: Diagnosis of variceal bleeding and dits control in cirrhosis

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 400 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Diagnosis of Variceal Bleeding and Its Control in Cirrhosis
Study Start Date : November 1999
Estimated Study Completion Date : June 2002

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding Cirrhosis
U.S. FDA Resources




Primary Outcome Measures :
  1. variceal bleeding


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cirrhotic patients admitted for an acute complication of cirrhosis
  • admission ≤ 6 hours of inclusion

Exclusion Criteria:

  • Child-Pugh score > 13
  • Digestive hemorrhage
  • Non cirrhotic portal hypertension

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00188097


Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Paul Cales, PHD UH Angers

ClinicalTrials.gov Identifier: NCT00188097     History of Changes
Other Study ID Numbers: PHRC 03-04
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: January 19, 2006
Last Verified: August 2005

Additional relevant MeSH terms:
Fibrosis
Liver Cirrhosis
Pathologic Processes
Liver Diseases
Digestive System Diseases